Hans Biomed Corporation operates within the Surgical appliances and supplies sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hans Biomed with three other
companies in this sector in South Korea:
Meta Biomed Co., Ltd.
sales of 63.81 billion Korean Won [US$54.69 million]
of which 50%
Sinsin Pharmaceutical Co Ltd
(63.72 billion Korean Won [US$54.61 million]
of which 48%
was Plaster), and
Solco Biomedical Co Ltd
(22.54 billion Korean Won [US$19.32 million]
of which 55%
was Healthcare Segment).
During the year ended September of 2018, sales at
Hans Biomed were 51.75 billion Korean Won (US$44.35 million).
increase of 32.5%
versus 2017, when the company's sales were 39.06 billion Korean Won.
This was the fifth consecutive year of sales increases at Hans Biomed
(and since 2013, sales have increased a total of 158%).
Sales of Medical Equipment saw an increase
that was more than double the company's growth rate: sales were up
339.9% in 2018, from
4.77 billion Korean Won to 21.00 billion Korean Won.